697762-39-3

Basic information

• Product Name: 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid ethyl ester
• Synonyms: 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid ethyl ester
• CAS NO: 697762-39-3
• Molecular Weight: 409.171
• Mol File: 697762-39-3.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid ethyl ester(697762-39-3)
• EPA Substance Registry System: 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid ethyl ester(697762-39-3)

Safety Data

• Hazardous Substances Data: 697762-39-3(Hazardous Substances Data)

Usage

Ethyl ester of 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid

This compound is derived from 2-(2,4-difluoro-5-iodobenzoyl)-3-diMethylaMinoacrylic acid by attaching an ethyl ester group.

Usage as a reagent in organic synthesis

It is commonly used as a reagent in organic synthesis due to its versatile structure and functional groups.

Building block for pharmaceuticals and agrochemicals

The presence of a carboxylic acid, an amino group, and a fluorinated benzoyl group makes it a valuable building block for the preparation of various pharmaceuticals and agrochemicals.

Unique reactivity from fluorine and iodine substituents

The presence of fluorine and iodine atoms on the benzoyl ring provides unique reactivity and potentially useful properties for the compound in various applications.

Easier handling and manipulation in laboratory settings

The ethyl ester group allows for easier handling and manipulation of the compound in laboratory settings.

Upstream product

• 412319-88-1 ethyl-3,3-dimethylaminoacrylate 
• 161531-51-7 2,4-difluoro-5-iodobenzoic acid 
• 1583-58-0 2,4-difluoro-benzoic acid 
• 924-99-2 ethyl 3-(dimethylamino)acrylate 

Downstream Products

• 697762-60-0 7-fluoro-1-(1(S)-hydroxymethyl-2-methylprop-1-yl)-6-iodo-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 1261283-91-3 6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-[2-methyl-1-(tetrahydropyran-2-yloxymethyl)prop-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 1261283-94-6 6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-((S)-1-hydroxymethyl-2-methylprop-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid dicyclohexylamine salt 
• 1261283-95-7 1(S)-[1-(tert-butyldimethylsilanyloxymethyl)-2-methylprop-1-yl]-6-(3-chloro-2-fluorobenzyl)-7-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 1261283-97-9 6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-[2-methyl-1-(tetrahydropyran-2-yloxymethyl)prop-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 1261283-99-1 1-(S)-[1-(tert-butyldimethylsilanyloxymethyl)-2-methylprop-1-yl]-6-(3-chloro-2-fluorobenzyl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 1261284-01-8 6-(3-chloro-2-fluorobenzyl)-7-methoxy-1-[1-(S)-2-methyl-1-(tetrahydropyran-2-yloxymethyl)prop-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 697762-59-7 C₁₇H₂₀F₂INO₄ 
• 697762-66-6 6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-[1-(S)-tert-butyldimethylsilyloxymethyl-2-methylprop-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 
• 697761-98-1 elvitegravir 
• 869893-92-5 6-(3-chloro-2-fluorobenzyl)-7-fluoro-1-((S)-1-hydroxymethyl-2-methylprop-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 
• 870294-02-3 1-((2S)-1-tert-butyldimethylsilyloxy-3-methylbutan-2-yl)-7-fluoro-6-iodo-4-oxo-1,4-dihydroquinoline-3-carboxylic acid ethyl ester 

Relevant articles and documents

A quinolone derivatives containing pyrimidine ring and its preparation and use

The invention belongs to the technical field of medicines and in particular relates to pyrimidine ring-containing quinolone derivatives as well as a preparation method and application thereof. A compound comprises pyrimidine ring-containing quinolone deri

HETEROCYCLIC UREA DERIVATIVES AND METHODS OF USE THEREOF

Compounds of formula (IA) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.

6- (Heterocyclyl-substituted Benzyl) -4-Oxoquinoline Compound and Use Thereof as HIV Integrase Inhibitor

The present invention relates to a compound represented by the following formula [I] wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical composition, an anti-HIV